Live news related to ADOCIA stock (FR0011184241): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on ADOCIA mainly cover M&A activity, earnings publications et analyst notes. The stock trades at €4,04 on Euronext Paris, down 3,44% at the last update. This page lists the articles published on ADOCIA stock to track the share price, company announcements and any item likely to influence market perception.
On Monday, during the annual scientific conference of the American Diabetes Association, Adocia presented the complete data from its phase 3 trial con…
Adocia has released its Q1 2026 financial results, showing a cash balance of EUR 12.0 million as of March 31, with a quarterly cash burn of EUR 5.1 mi…
The stock of the Lyon-based biotech company marked a significant rebound this Tuesday, April 28, reaching 4.906 euros after closing at 4.644 euros the…
Biopharmaceutical company Adocia has announced the signing of a current account advance agreement with Vester Finance, for a total amount of 6 million…
Adocia announced the completion of the Phase 3 program for BioChaperone® Lispro with its Chinese partner Tonghua Dongbao, showing positive results in …
The Lyon-based biopharmaceutical company Adocia has announced the dates for its financial publications and general assembly for the fiscal year 2026.
Lyon-based biopharmaceutical company Adocia has announced the publication dates for its financial and operational indicators for the year 2026, accord…
Biopharmaceutical company Adocia announces the filing of a patent for its AdoXLong platform, aimed at extending the action of peptides to one month.
Adocia and its partner Tonghua Dongbao have announced positive results from a Phase 3 clinical trial of BioChaperone® Lispro, an ultra-rapid insulin, …
Adocia has released its financial results for the third quarter of 2025 and reported clinical progress on its ultra-rapid BioChaperone® Lispro insulin…
